Xueqing Hu

Xuzhou Medical College

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations”.

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations

Annals of Oncology(2020)10.1016/j.annonc.2020.10.599

N/A

0DataRank · unranked

249 citations

Tao Shen, S. Terzyan, X. Liu, Xueqing Hu, Khadijah Patel +8 more

The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib

npj Precision Oncology(2021)10.1038/s41698-021-00188-x

N/A

0DataRank · unranked

49 citations

Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H. M. Mooers, Jie Wu +1 more

Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0629

N/A

0DataRank · unranked

14 citations

Neetu Dayal, Xueqing Hu, Elizabeth Larocque, Nimishetti Naganna, Tao Shen +6 more

The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases

Drug Resistance Updates(2023)10.1016/j.drup.2023.100958

N/A

0DataRank · unranked

12 citations

Xuan Liu, Ujjwol Khatri, Jie Wu, Xueqing Hu

Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model

Cancer Letters(2025)10.1016/j.canlet.2025.217444

N/A

0DataRank · unranked

3 citations

Mohamed A. Gouda, Shriya Pandey, Neeraj Chauhan, Tao Shen, Xueqing Hu +5 more

Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy

RSC Medicinal Chemistry(2025)10.1039/d5md00245a

N/A

0DataRank · unranked

1 citations

Neetu Dayal, Kofi Baffour-Awuah Owusu, Mandeep Kaur Hunjan, Shriya Pandey, H. Harper +14 more